Skip to main content
. Author manuscript; available in PMC: 2013 Nov 12.
Published in final edited form as: Chemotherapy. 2012 Nov 12;58(4):321–329. doi: 10.1159/000343165

Table 1.

Dose Escalation Scheme

Dose Level (Cohort) ABT-751 mg BID (not mg/m2) Carboplatin AUC Planned enrollment Enrolled patients
1 100 4.5 1–6 1
2 125 4.5 1–6 1
3## 125 6 1–6 5
4 150 6 3–6 5
5 175 6 3–6 0
6 200 6 3–6 0
Expansion cohort MTD MTD 10 7
##

After dose-limiting toxicities (DLTs) were identified at dose level 4, additional 4 patients were enrolled at the level 3 dose (patients 10, 11, 12, 13).